GlassScriptPhysician profile
Leonard R Geiger
NPI 1588741557
$1,508.13
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $894 · 2020: $262 · 2021: $220 · 2023: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $339.11 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $330.04 | 2019-2021 | |
| Biogen, INC. | $149.08 | 2019-2021 | |
| Grifols USA, LLC | $132.27 | 2023 | Prolastin-C Liquid |
| Ucb, INC. | $115.80 | 2019-2021 | |
| Genzyme Corporation | $53.29 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $51.65 | 2019-2021 | |
| Allergan, INC. | $47.26 | 2020 | |
| Kyowa Kirin, INC. | $46.78 | 2021 | |
| Acorda Therapeutics, INC | $43.31 | 2019 | |
| Alexion Pharmaceuticals, INC. | $35.15 | 2019-2020 | |
| Amgen INC. | $31.38 | 2019 | |
| Sunovion Pharmaceuticals INC. | $27.46 | 2019 | |
| Abbvie INC. | $25.63 | 2021 | |
| Bausch Health US, LLC | $22.94 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $19.40 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.52 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.90 | 2019 | |
| Akcea Therapeutics, INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Geiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.